GENEXINE
Genexine is a clinical stage biotechnology company focused on the development and commercialization of innovative immunotherapeutics and next generation novel long-acting biologics. Our goal is to bring to patients medicines that will transform their lives.
GENEXINE
Industry:
Biotechnology Health Care Life Science Medical
Founded:
1999-06-08
Address:
Seongnam, Kyonggi-do, South Korea
Country:
South Korea
Website Url:
http://www.genexine.com
Total Employee:
101+
Status:
Active
Contact:
+82316283200
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager Google Universal Analytics Global Site Tag Mobile Non Scaleable Content Nginx
Similar Organizations
Reset Pharmaceuticals
Reset Pharma is a biotechnology company that focuses on the development and commercialization of novel psychedelic treatments.
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-12-14 | ToolGen | Genexine investment in Corporate Round - ToolGen | N/A |
| 2017-03-23 | I-Mab Biopharma | Genexine investment in Series B - I-Mab Biopharma | 150 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2022-05-24 | Genexine Appoints Industry Veteran Neil Warma as Chief Executive Officer to Accelerate Global Growth, Product Commercialization and Innovation |
Official Site Inspections
http://www.genexine.com Semrush global rank: 6.68 M Semrush visits lastest month: 874
- Host name: 210.114.6.138
- IP address: 210.114.6.138
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
More informations about "Genexine"
Genexine
Jaehyun as a CEO and the Head of R&D is in charge of all R&D-related divisions of the company, including Genexine's bio laboratory and clinical development headquarters, based on over 15 years of diverse experience working in the …See details»
Genexine - Crunchbase Company Profile & Funding
Genexine is a clinical stage biotechnology company focused on the development and commercialization of innovative immunotherapeutics.See details»
Genexine
Address 07789, 172, Magokjungang-ro, Gangseo-gu, Seoul, Republic of KoreaSee details»
Genexine, Inc. - LinkedIn
Genexine, Inc. is a publicly traded, clinical-stage biotechnology company focused on developing and commercializing immunotherapeutics and next-generation . Its primary technology platforms are Therapeutic DNA vaccine and hyFc® long …See details»
Genexine Inc Company Profile - GlobalData
Up-to-date Genexine Inc company overview including funding information, company profile, key statistics, peer comparison and more.See details»
Genexine Company Profile | Management and Employees List
Genexine Profile and History Genexine, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of immunotherapeutics and long-acting biologics in …See details»
Genexine Company Profile - Office Locations, Competitors ... - Craft
Oct 29, 2024 Genexine has 5 employees across 2 locations and ₩4.43 b in annual revenue in FY 2023. See insights on Genexine including office locations, competitors, revenue, financials, …See details»
Genexine Inc. Company Profile - South Korea | Financials & Key
Apr 10, 2025 Report with financial data, key executives contacts, ownership details & and more for Genexine Inc. in South Korea. Report is available for immediate purchase & download from …See details»
Genexine
Genexine is a leading biopharmaceutical company focused on developing innovative therapies for cancer, rare diseases, and biobetter treatments. With a foundation rooted in continuous technological innovation and a deep respect …See details»
Genexine - VentureRadar
"Genexine in involved in the research and development (R&D) of innovative immunotherapeutic drugs and next-generation antibody fusion proteins. The company is also actively involved in …See details»
Genexine
Genexine is a leading biopharmaceutical company focused on discovering, developing and commercializing first and best-in-class immunotherapies for cancer and antibody therapies for rare diseases.See details»
Genexine, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Genexine, Inc. with its drug pipeline, therapeutic area, technology platform, 43 clinical trials, 32 news, and 31 literature, Disease Domain:Immune System Diseases, Neoplasms, …See details»
Eastern District of Pennsylvania | Genetic Testing Marketing …
3 days ago PHILADELPHIA – United States Attorney David Metcalf announced today that Genexe, LLC, Immerge, Inc., Jason Green, and Jason Gross have agreed to pay $6 million to …See details»
Genexine
Genexine’s vision of treating patients and improving their quality of life is being practically realized owing to faster and more accurate drug development based on clinical planning and …See details»
Genexine
Prior to joining Genexine, she worked in Daewoong Pharmaceutical Business Development and Marketing for Korean market division where she performed key business alliance successfully …See details»
Genexine
We are excited about the potential and the future of Genexine as we make the exciting transition from a research based organization to one focused on the commercialization of our first …See details»
Genexine
Feb 3, 2023 Corporate Presentation We create sustainable value for patients, employees, shareholders and societySee details»
Genexine
Genexine’s vision of treating patients and improving their quality of life is being practically realized owing to faster and more accurate drug development based on clinical planning and …See details»
Genexine
Genexine fulfills its social responsibilities as a corporate citizen by complying with international standards, international agreements, national policies, and laws.See details»
Genexine
Stock Information We create sustainable value for patients, employees, shareholders and societySee details»